APA
BHVN

American Portfolios Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

American Portfolios Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$13K Sell
86
-28
-25% -$4.15K ﹤0.01% 2400
2022
Q2 		$16.6K Buy
+114
New +$14.6K ﹤0.01% 2322
2021
Q2 		– Sell
-545
Closed -$37.3K – 3506
2021
Q1 		$37.3K Buy
+545
New +$44.1K ﹤0.01% 1733

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Portfolios Advisors's BHVN Position: Q3 2022 in Review

American Portfolios Advisors reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 25% in Q3 2022, selling an estimated $4.15K and leaving 86 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

American Portfolios Advisors first reported a position in BHVN in Q1 2021 and has held it in 3 quarters since. The position peaked at $37.3K in Q1 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • American Portfolios Advisors held 86 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $13K as of Q3 2022.
  • American Portfolios Advisors sold 28 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $4.15K.
  • Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2400 holding.
  • American Portfolios Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2021 and has held it in 3 quarters since.
  • American Portfolios Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $37.3K in Q1 2021.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.